Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes

Diabetes Care

Volumn 28, Issue 8, 2005, Pages 1916-1921

  Liu, Jian ^a   Sempos, Christopher ^b   Donahue, Richard P ^c   Dorn, Joan ^c   Trevisan, Maurizio ^c   Grundy, Scott M ^d  

^a BROCK UNIVERSITY   (Canada)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; RISK ASSESSMENT; STATISTICAL MODEL;

ADULT; BLOOD PRESSURE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 23044485065     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.8.1916     Document Type: Article

References (30)

1. Grundy SM, Howard B, Smith S Jr, Eckel R, Redberg R, Bonow RO: Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for Healthcare professionals from a special writing group of the American Heart Association. Circulation 105:2231-2239, 2002
2. Garg A, Grundy SM: Management of dyslipidemia in NIDDM. Diabetes Care 13: 153-169, 1990
3. Haffner SM: Management of dyslipidemia in adults with diabetes (Technical Review). Diabetes Care 21:160-178, 1998
4. American Diabetes Association: Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care 25:S74-S77, 2002
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001
6. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
7. Demacker PN, Hijmans AG, Brenninkmeijer BJ, Jansen AP, van 't Laar A: Five methods for determining low-density lipoprotein cholesterol compared. Clin Chem 30:1797-1800, 1984
8. Dawber TR: The Framingham Study. The Epidemiology of Atherosclerotic Disease. Cambridge, MA, Harvard University Press, 1980
9. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 110:281-290, 1979
10. The Lipid Research Clinics Program Epidemiology Committee: Plasma lipid distributions in selected North American populations: the lipid Research Clinics Program Prevalence Study. Circulation 60: 427-439, 1979
11. Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 248:1465-1477, 1982
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
13. Cooper GR: Methods for Determining the Amount of Glucose in Blood. CRC Crit Rev Clin Lab Sci 4:101-145, 1973
14. Barthelmai W, Czok R: [Enzymatic determinations of glucose in the blood, cerebrospinal fluid and urine.] Klin Wochenschr 40:585-589, 1962 [article in German]
15. Abell LL, Levy RI, Brodie BB, Kendall FE: Simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 195: 357-366, 1952
16. Kessler G, Lederer H: Flourometric measurements of triglycerides of triglycerides. In Technicon Symposia: Automation in Analytical Chemistry. Skeggs LT, Ed. New York, 1965, p. 341-344
17. LRC Program: Manual of Laboratory Options, Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. Vol 1. Bethesda, MD, National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Dept of Health, Education and Welfare, 1982
18. Califf RM, Mark DB, Harrell FE Jr, Hlatky MA, Lee KL, Rosati RA, Pryor DB: Importance of clinical measure of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol 11:20-26, 1988
19. World Health Organization: International Classification of Diseases: Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Ninth revision. Vol. 1. Geneva, World Health Organization, 1977, p. 15-17
20. Multiple Risk Factor Intervention Trial Research Group: Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 82:1616-1628, 1990
21. Sempos C, Cooper R, Kovar MG, McMillen M: Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States. Am J Public Health 78:1422-1427, 1988
22. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P: Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening maker. Am J Epidemiol 159:882-890, 2004
23. Kattan MW: Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 95:634-635, 2003
24. Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB: Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 27: 1991-1997, 2004
25. Lehto S, Rönnemaa T, Haffner SM, Kallio V, Laakso M: Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 46:1354-1359, 1997
26. Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV: Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care 26:16-23, 2003
27. Collins R, Armitage J, Parish S, Sleigh P, Peto R, Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005-2016, 2003
28. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ, National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227-239, 2004
29. [erratum Circulation 110:763, 2004].
30. Grundy SM: Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 106:2526-2529, 2002